LV12452B - Aktīvās vielas vagināla ievadīšanas sistēma - Google Patents

Aktīvās vielas vagināla ievadīšanas sistēma Download PDF

Info

Publication number
LV12452B
LV12452B LVP-99-169A LV990169A LV12452B LV 12452 B LV12452 B LV 12452B LV 990169 A LV990169 A LV 990169A LV 12452 B LV12452 B LV 12452B
Authority
LV
Latvia
Prior art keywords
sleeve
support means
delivery system
active
core
Prior art date
Application number
LVP-99-169A
Other languages
English (en)
Other versions
LV12452A (lv
Inventor
Matti Lehtinen
Christine Talling
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of LV12452A publication Critical patent/LV12452A/lv
Publication of LV12452B publication Critical patent/LV12452B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00—Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06—Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08—Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Claims (11)

  1. LV 12452 IZGUDROJUMA FORMULA 1. Aktīvās vielas vagināla ievadīšanas sistēma, kas satur elastīgus atbalsta līdzekļus un padeves līdzekļus, kurus balsta atbalsta līdzekļi un kuri satur aktīvo vielu, raksturojas ar to, ka atbalsta līdzekļi (1) sastāv no serdeņa (Γ) būtībā ar atvērta gredzena formu un ka padeves līdzekļi sastāv vismaz no viena uzmavai līdzīga ķermeņa (2) no polimēra materiāla, kas daļā 10 serdeņa garuma jostveidīgi apņem serdeni.
  2. 2. Ievadīšanas sistēma saskaņā ar 1. punktu, kas raksturojas ar to, ka uzmavai līdzīgais ķermenis ir no polisiloksāna, piemēram no polidimetilsiloksāna, poliuretāna vai etilvinilacetāta (EVA) kopolimēra. 15
  3. 3. Ievadīšanas sistēma saskaņā ar 1. punktu, kas raksturojas ar to, ka atbalsta līdzekļi sastāv no sašūta kaučuka, piemēram dabiskā kaučuka, butilkaučuka un polidimetilsiloksāna elastomēra, elastīgiem termoplastiskiem sveķiem, piemēram etilvinilacetāta (EVA), termoplastiska elastomēra, 20 piemēram stirola kopolimēra (SEBS, SBS, SIS), poliuretāna vai termoplastiska poliolefīna.
  4. 4. Ievadīšanas sistēma saskaņā ar 1. punktu, kas raksturojas ar to, ka uzmavai līdzīgā ķermeņa iekšējā virsma kontaktē ar tāda materiāla slāni, kas 25 būtībā novērš aktīvās vielas migrāciju no uzmavai līdzīgā ķermeņa atbalsta līdzekļos.
  5. 5. Ievadīšanas sistēma saskaņā ar 1. punktu, kas raksturojas ar to, ka atbalsta līdzekļu ārējā virsma vai atbalsta līdzekļi pilnībā ir izgatavoti no 30 materiāla, kas novērš aktīvās vielas migrāciju no uzmavai līdzīgā ķermeņa atbalsta līdzekļos.
  6. 6. Ievadīšanas sistēma saskaņā ar 1. punktu, kas raksturojas ar to, ka padeves līdzekļi ir veidoti no diviem uzmavai līdzīgiem ķermeņiem, pie tam 35 katrs no tiem satur citu aktīvo vielu. 2
  7. 7. Ievadīšanas sistēma saskaņā ar 1. punktu, kas raksturojas ar to, ka uzmavai līdzīgais ķermenis satur gestagēnu aktīvo vielu vai estrogēnu aktīvo vielu.
  8. 8. Ievadīšanas sistēma saskaņā ar 1. punktu, kas raksturojas ar to, ka tā satur divus uzmavai līdzīgos ķermeņus, pie tam tie abi satur vienu un to pašu aktīvo vielu.
  9. 9. Ievadīšanas sistēma saskaņā ar 1. punktu, kas raksturojas ar to, ka 10 uzmavai līdzīgais ķermenis ir pārklāts ar membrānu (4), kas ļauj difundēt aktīvajai vielai, galvenokārt ar poiisiloksāna membrānu.
  10. 10. Paņēmiens ievadīšanas sistēmas saskaņā ar 1. punktu izgatavošanai, raksturojas ar to, ka tiek palielināts aktīvo vielu un polimēru saturošā 15 uzmavai līdzīgā ķermeņa diametrs, piemēram izstiepjot, piemēram mehāniski vai uzbriedinot, šādā stāvoklī tas tiek novietots uz serdeņa un tiek atstāts, lai savilktos uz atbalsta līdzekļiem.
  11. 11. Paņēmiens saskaņā ar 10. punktu, kas raksturojas ar to, ka uzmavai 20 līdzīgais ķermenis ir izgatavots koekstrūzijas ceļā kopā ar polimēra membrānu, kas tiek darīts, lai uz uzmavas veidotu ārējo slāni, kad tā uzmontēta uz serdeņa.
LVP-99-169A 1993-06-17 1999-12-01 Aktīvās vielas vagināla ievadīšanas sistēma LV12452B (lv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI932789A FI95768C (fi) 1993-06-17 1993-06-17 Emättimensisäinen antosysteemi

Publications (2)

Publication Number Publication Date
LV12452A LV12452A (lv) 2000-04-20
LV12452B true LV12452B (lv) 2000-09-20

Family

ID=8538154

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-99-169A LV12452B (lv) 1993-06-17 1999-12-01 Aktīvās vielas vagināla ievadīšanas sistēma

Country Status (24)

Country Link
US (1) US5694947A (lv)
EP (1) EP0703802B1 (lv)
JP (1) JP3803714B2 (lv)
KR (1) KR100312764B1 (lv)
CN (1) CN1126574C (lv)
AT (1) ATE177657T1 (lv)
AU (1) AU674758B2 (lv)
BR (1) BR9407118A (lv)
CZ (1) CZ284989B6 (lv)
DE (1) DE69417232T2 (lv)
DK (1) DK0703802T3 (lv)
EE (1) EE03202B1 (lv)
ES (1) ES2130423T3 (lv)
FI (1) FI95768C (lv)
GR (1) GR3030565T3 (lv)
HU (1) HU217950B (lv)
LT (1) LT3455B (lv)
LV (1) LV12452B (lv)
MY (1) MY113965A (lv)
NO (1) NO311498B1 (lv)
PL (1) PL176664B1 (lv)
RU (1) RU2121824C1 (lv)
TW (1) TW286273B (lv)
WO (1) WO1995000199A1 (lv)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
DE69929055T2 (de) * 1998-05-01 2006-07-20 Duramed Pharmaceuticals Inc., Cincinnati Verfahren zur spritzgussherstellung von vorrichtungen mit kontrollierter wirkstofffreisetzung und damit hergestellte vorrichtung
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
GB0009914D0 (en) 2000-04-20 2000-06-07 Metris Therapeutics Limited Device
WO2005004837A1 (en) * 2003-07-10 2005-01-20 Galen (Chemicals) Limited Intravaginal drug delivery devices
US7862552B2 (en) * 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US8173593B2 (en) 2005-07-19 2012-05-08 The Population Council, Inc. Methods and compositions for emergency contraception using endothelin receptor antagonists
JP2010509964A (ja) * 2006-11-20 2010-04-02 ナームローゼ・フエンノートチヤツプ・オルガノン らせん形薬物送達システム
TW200927141A (en) * 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2062568A1 (en) * 2007-11-22 2009-05-27 Bayer Schering Pharma Oy Vaginal delivery system
US20110045076A1 (en) * 2008-01-25 2011-02-24 Kiser Patrick F Linear order release polymer
MX337634B (es) * 2008-02-04 2016-03-14 Teva Womens Health Inc Anillos intravaginales monoliticos que comprenden progesterona y metodos de manufactura y uso de los mismos.
FI20095550A0 (fi) * 2009-05-19 2009-05-19 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
FI20095563A (fi) * 2009-05-20 2010-11-21 Bayer Schering Pharma Oy Vaginaalinen antojärjestelmä
EP4108216A1 (en) 2009-06-03 2022-12-28 Forsight Vision5, Inc. Anterior segment drug delivery
DE102010003494A1 (de) * 2010-03-31 2011-10-06 Bayer Schering Pharma Aktiengesellschaft Parenterales Abgabesystem, das Aromatasehemmer und Gestagene freisetzt, für die Behandlung von Endometriose
US8939948B2 (en) 2010-06-01 2015-01-27 Forsight Vision5, Inc. Ocular insert apparatus and methods
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2749286B1 (en) 2011-08-26 2017-03-01 Universidad De Santiago De Chile Use of non-steroidal anti-inflammatory drugs meloxicam and piroxicam, administered intravaginally, for interruption of a woman's ovulation process
GB201115592D0 (en) * 2011-09-09 2011-10-26 Vivosens Medical Gmbh Flexible ring pessary
CN103007427B (zh) * 2011-09-21 2016-01-20 上海市计划生育科学研究所 缓控释宫内释药器及其制备方法
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2885523T3 (es) 2011-11-23 2021-12-14 Therapeuticsmd Inc Formulaciones y terapias de reposición hormonal de combinación naturales
EP2641602A1 (en) 2012-03-23 2013-09-25 PregLem S.A. Method for treating gynecological diseases
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
KR20150051234A (ko) 2012-09-03 2015-05-11 에쏘세아 파르밍 에쎄.아. 수생 생물종의 배향 및／또는 억제를 위한 저장조 케이지 침지 시스템
PT2911623T (pt) 2012-10-26 2019-11-21 Forsight Vision5 Inc Sistema oftálmico para libertação prolongada de fármaco no olho
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AR095831A1 (es) 2013-04-10 2015-11-11 Preglem Sa Moduladores de los receptores de progesterona útiles en la terapia de los fibroides uterinos
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CN106456838B (zh) * 2014-04-01 2020-12-29 保利医学公司 避孕装置及相关装置
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
ES2940478T3 (es) * 2014-06-26 2023-05-08 Taris Biomedical Llc Dispositivos de administración de fármacos intravesicales y métodos que incluyen sistemas de matriz de polímero-fármaco elásticos
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
CN110403565B (zh) * 2018-04-27 2022-02-11 西安交通大学医学院第一附属医院 一种胶囊内窥镜磁与麦芒仿生双驱动装置
CN109771124A (zh) * 2019-01-31 2019-05-21 山东省药学科学院 一种具有形状记忆功能的子宫托
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1264731A (en) * 1917-03-19 1918-04-30 Carl Willers Pneumatic die-cushion.
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US3911911A (en) * 1969-06-16 1975-10-14 Reese Hospital Michael Anti-fertility device
US3920805A (en) * 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
GB1465684A (en) * 1973-07-27 1977-02-23 Emmett L Contraceptive device
IL48277A (en) * 1974-10-18 1978-03-10 Schering Ag Vaginal ring
DE2616064A1 (de) * 1976-04-09 1977-10-20 Schering Ag Vaginalring iii
US3995634A (en) * 1975-12-02 1976-12-07 The Procter & Gamble Company Vaginal cavity dispensing means and method
US4215691A (en) * 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4292965A (en) * 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (de) * 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen Vaginalring
ATE21331T1 (de) * 1981-12-30 1986-08-15 Population Council Inc Verfahren zur herstellung von intrauterinen vorrichtungen.
JPS5919151U (ja) * 1982-07-28 1984-02-06 ニツポ−株式会社 痔疾治療器
GB8403138D0 (en) * 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
EP0180264A1 (en) * 1984-10-12 1986-05-07 Akzo N.V. Release system for two or more active substances
ZA857643B (en) * 1984-10-12 1986-05-28 Akzo Nv Release system for two or more active substances
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices
US4822161A (en) * 1988-01-19 1989-04-18 Jimmy Michael F Illuminating spectacle apparatus
JPH02185264A (ja) * 1988-12-16 1990-07-19 Ferring Bv 膀胱内又は尿管へ薬を送り込む方法及び装置
KR100236355B1 (ko) * 1990-03-16 2000-01-15 이데이 노부유끼 와이프 패턴의 발생장치
JP3186105B2 (ja) * 1991-07-26 2001-07-11 日本電気株式会社 半導体装置のテストモード設定・解除回路
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi

Also Published As

Publication number Publication date
CZ284989B6 (cs) 1999-04-14
FI95768B (fi) 1995-12-15
RU2121824C1 (ru) 1998-11-20
HU217950B (hu) 2000-05-28
NO955029L (no) 1995-12-12
TW286273B (lv) 1996-09-21
EP0703802A1 (en) 1996-04-03
ES2130423T3 (es) 1999-07-01
HUT74548A (en) 1997-01-28
HU9503290D0 (en) 1996-01-29
FI95768C (fi) 1996-03-25
KR960703024A (ko) 1996-06-19
LT3455B (en) 1995-10-25
MY113965A (en) 2002-07-31
AU6848194A (en) 1995-01-17
LTIP1957A (en) 1995-01-31
FI932789A0 (fi) 1993-06-17
DE69417232D1 (de) 1999-04-22
WO1995000199A1 (en) 1995-01-05
CZ320895A3 (en) 1996-07-17
DK0703802T3 (da) 1999-10-11
ATE177657T1 (de) 1999-04-15
JPH08511240A (ja) 1996-11-26
DE69417232T2 (de) 1999-11-04
FI932789A (fi) 1994-12-18
EP0703802B1 (en) 1999-03-17
US5694947A (en) 1997-12-09
GR3030565T3 (en) 1999-10-29
NO311498B1 (no) 2001-12-03
LV12452A (lv) 2000-04-20
AU674758B2 (en) 1997-01-09
JP3803714B2 (ja) 2006-08-02
KR100312764B1 (ko) 2002-11-23
CN1126574C (zh) 2003-11-05
BR9407118A (pt) 1996-09-03
NO955029D0 (no) 1995-12-12
PL312193A1 (en) 1996-04-01
PL176664B1 (pl) 1999-07-30
EE03202B1 (et) 1999-08-16
CN1125403A (zh) 1996-06-26

Similar Documents

Publication Publication Date Title
LV12452B (lv) Aktīvās vielas vagināla ievadīšanas sistēma
KR100492676B1 (ko) 2종이상의활성물질을위한약물전달시스템
JP2571831B2 (ja) 避妊用インプラント
AU607172B2 (en) Diffusion matrix for transdermal drug administration
US5756115A (en) Contraceptive method using a subdermally implantable device
AU657502B2 (en) Transdermal contraceptive formulations, methods and devices
CA2216943A1 (en) Drug release coated stent
RU96101160A (ru) Внутривлагалищная система доставки
AU4043197A (en) Intravaginal rings with insertable drug-containing core
NZ234881A (en) Biphasic transdermal drug delivery device
NZ252598A (en) Device for the transdermal administration of oxybutynin (or salts thereof) comprising a backing material, drug reservoir having a permeation enhancer and means of contact with the skin
WO1992007589A1 (en) Transdermal contraceptive formulations, methods and devices
NZ223894A (en) Active substance-containing plaster for controlled administration of active agents to skin
WO2010133757A1 (en) Vaginal delivery system
JP3172395B2 (ja) 経皮薬剤放出デバイス
CA2165282C (en) Intravaginal delivery system
AU727267B2 (en) Patch for transdermal application of pergolid
MXPA98002799A (en) System of delivery of medication for two or massubstancias acti